ID   UD2B7_HUMAN             Reviewed;         529 AA.
AC   P16662; B2R810; Q6GTW0;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1990, sequence version 1.
DT   10-MAY-2017, entry version 166.
DE   RecName: Full=UDP-glucuronosyltransferase 2B7;
DE            Short=UDPGT 2B7;
DE            EC=2.4.1.17;
DE   AltName: Full=3,4-catechol estrogen-specific UDPGT;
DE   AltName: Full=UDP-glucuronosyltransferase 2B9;
DE            Short=UDPGT 2B9;
DE   AltName: Full=UDPGTh-2;
DE   Flags: Precursor;
GN   Name=UGT2B7; Synonyms=UGTB2B9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=2159463;
RA   Ritter J.K., Sheen Y.Y., Owens I.S.;
RT   "Cloning and expression of human liver UDP-glucuronosyltransferase in
RT   COS-1 cells. 3,4-catechol estrogens and estriol as primary
RT   substrates.";
RL   J. Biol. Chem. 265:7900-7906(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT TYR-268.
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT TYR-268.
RC   TISSUE=Kidney;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT TYR-268.
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT TYR-268.
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-68.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 285-451, CATALYTIC ACTIVITY,
RP   FUNCTION TOWARDS STEROIDS, AND MUTAGENESIS OF SER-15; HIS-35; ASP-151;
RP   THR-373; HIS-374; ASN-378; GLY-379; ASP-398 AND GLN-399.
RX   PubMed=17442341; DOI=10.1016/j.jmb.2007.03.066;
RA   Miley M.J., Zielinska A.K., Keenan J.E., Bratton S.M.,
RA   Radominska-Pandya A., Redinbo M.R.;
RT   "Crystal structure of the cofactor-binding domain of the human phase
RT   II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7.";
RL   J. Mol. Biol. 369:498-511(2007).
RN   [9]
RP   VARIANT UGT2B7*2 TYR-268.
RX   PubMed=11186130; DOI=10.1097/00008571-200011000-00002;
RA   Bhasker C.R., McKinnon W., Stone A., Lo A.C., Kubota T., Ishizaki T.,
RA   Miners J.O.;
RT   "Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at
RT   amino acid 268: ethnic diversity of alleles and potential clinical
RT   significance.";
RL   Pharmacogenetics 10:679-685(2000).
CC   -!- FUNCTION: UDPGT is of major importance in the conjugation and
CC       subsequent elimination of potentially toxic xenobiotics and
CC       endogenous compounds. {ECO:0000269|PubMed:17442341}.
CC   -!- FUNCTION: Its unique specificity for 3,4-catechol estrogens and
CC       estriol suggests it may play an important role in regulating the
CC       level and activity of these potent and active estrogen
CC       metabolites. Is also active with androsterone, hyodeoxycholic acid
CC       and tetrachlorocatechol (in vitro). {ECO:0000269|PubMed:17442341}.
CC   -!- CATALYTIC ACTIVITY: UDP-glucuronate + acceptor = UDP + acceptor
CC       beta-D-glucuronoside. {ECO:0000269|PubMed:17442341}.
CC   -!- SUBCELLULAR LOCATION: Microsome membrane {ECO:0000305}; Single-
CC       pass membrane protein {ECO:0000305}. Endoplasmic reticulum
CC       membrane {ECO:0000305}; Single-pass membrane protein
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the UDP-glycosyltransferase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J05428; AAA36793.1; -; mRNA.
DR   EMBL; AK313190; BAG36007.1; -; mRNA.
DR   EMBL; AK223142; BAD96862.1; -; mRNA.
DR   EMBL; AC111000; AAY41045.1; -; Genomic_DNA.
DR   EMBL; BC030974; AAH30974.1; -; mRNA.
DR   CCDS; CCDS3526.1; -.
DR   PIR; A35366; A35366.
DR   RefSeq; NP_001065.2; NM_001074.3.
DR   RefSeq; NP_001317648.1; NM_001330719.1.
DR   UniGene; Hs.654424; -.
DR   PDB; 2O6L; X-ray; 1.80 A; A/B=285-451.
DR   PDBsum; 2O6L; -.
DR   ProteinModelPortal; P16662; -.
DR   SMR; P16662; -.
DR   BioGrid; 113211; 2.
DR   IntAct; P16662; 1.
DR   STRING; 9606.ENSP00000304811; -.
DR   BindingDB; P16662; -.
DR   ChEMBL; CHEMBL4370; -.
DR   DrugBank; DB06403; Ambrisentan.
DR   DrugBank; DB01076; Atorvastatin.
DR   DrugBank; DB00564; Carbamazepine.
DR   DrugBank; DB06777; Chenodeoxycholic acid.
DR   DrugBank; DB00318; Codeine.
DR   DrugBank; DB06695; Dabigatran etexilate.
DR   DrugBank; DB06292; Dapagliflozin.
DR   DrugBank; DB00586; Diclofenac.
DR   DrugBank; DB00445; Epirubicin.
DR   DrugBank; DB00749; Etodolac.
DR   DrugBank; DB00973; Ezetimibe.
DR   DrugBank; DB01544; Flunitrazepam.
DR   DrugBank; DB00712; Flurbiprofen.
DR   DrugBank; DB01095; Fluvastatin.
DR   DrugBank; DB01050; Ibuprofen.
DR   DrugBank; DB00328; Indomethacin.
DR   DrugBank; DB00678; Losartan.
DR   DrugBank; DB00227; Lovastatin.
DR   DrugBank; DB01252; Mitiglinide.
DR   DrugBank; DB00295; Morphine.
DR   DrugBank; DB00688; Mycophenolate mofetil.
DR   DrugBank; DB01024; Mycophenolic acid.
DR   DrugBank; DB00788; Naproxen.
DR   DrugBank; DB00842; Oxazepam.
DR   DrugBank; DB08860; Pitavastatin.
DR   DrugBank; DB06207; Silodosin.
DR   DrugBank; DB00641; Simvastatin.
DR   DrugBank; DB00870; Suprofen.
DR   DrugBank; DB06204; Tapentadol.
DR   DrugBank; DB00197; Troglitazone.
DR   DrugBank; DB00313; Valproic Acid.
DR   DrugBank; DB06737; Zaltoprofen.
DR   DrugBank; DB00495; Zidovudine.
DR   CAZy; GT1; Glycosyltransferase Family 1.
DR   iPTMnet; P16662; -.
DR   PhosphoSitePlus; P16662; -.
DR   BioMuta; UGT2B7; -.
DR   DMDM; 136727; -.
DR   EPD; P16662; -.
DR   MaxQB; P16662; -.
DR   PaxDb; P16662; -.
DR   PeptideAtlas; P16662; -.
DR   PRIDE; P16662; -.
DR   DNASU; 7364; -.
DR   Ensembl; ENST00000305231; ENSP00000304811; ENSG00000171234.
DR   GeneID; 7364; -.
DR   KEGG; hsa:7364; -.
DR   UCSC; uc003heg.4; human.
DR   CTD; 7364; -.
DR   DisGeNET; 7364; -.
DR   GeneCards; UGT2B7; -.
DR   HGNC; HGNC:12554; UGT2B7.
DR   HPA; HPA045108; -.
DR   MalaCards; UGT2B7; -.
DR   MIM; 600068; gene.
DR   neXtProt; NX_P16662; -.
DR   PharmGKB; PA361; -.
DR   eggNOG; KOG1192; Eukaryota.
DR   eggNOG; COG1819; LUCA.
DR   HOGENOM; HOG000220831; -.
DR   HOVERGEN; HBG004033; -.
DR   InParanoid; P16662; -.
DR   KO; K00699; -.
DR   OrthoDB; EOG091G06JC; -.
DR   PhylomeDB; P16662; -.
DR   TreeFam; TF315472; -.
DR   BioCyc; MetaCyc:HS10272-MONOMER; -.
DR   BRENDA; 2.4.1.17; 2681.
DR   Reactome; R-HSA-156588; Glucuronidation.
DR   SABIO-RK; P16662; -.
DR   SIGNOR; P16662; -.
DR   ChiTaRS; UGT2B7; human.
DR   EvolutionaryTrace; P16662; -.
DR   GeneWiki; UGT2B7; -.
DR   GenomeRNAi; 7364; -.
DR   PRO; PR:P16662; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000171234; -.
DR   CleanEx; HS_UGT2B7; -.
DR   ExpressionAtlas; P16662; baseline and differential.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0015020; F:glucuronosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0008209; P:androgen metabolic process; IDA:UniProtKB.
DR   GO; GO:0052695; P:cellular glucuronidation; IDA:UniProtKB.
DR   GO; GO:0006629; P:lipid metabolic process; TAS:ProtInc.
DR   InterPro; IPR002213; UDP_glucos_trans.
DR   PANTHER; PTHR11926; PTHR11926; 1.
DR   Pfam; PF00201; UDPGT; 1.
DR   PROSITE; PS00375; UDPGT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Endoplasmic reticulum; Glycoprotein;
KW   Glycosyltransferase; Lipid metabolism; Membrane; Microsome;
KW   Polymorphism; Reference proteome; Signal; Steroid metabolism;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     23       {ECO:0000250}.
FT   CHAIN        24    529       UDP-glucuronosyltransferase 2B7.
FT                                /FTId=PRO_0000036031.
FT   TRANSMEM    493    509       Helical. {ECO:0000255}.
FT   NP_BIND     373    379       UDP-glucuronic acid. {ECO:0000305}.
FT   BINDING     398    398       UDP-glucuronic acid. {ECO:0000305}.
FT   CARBOHYD     67     67       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     68     68       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    315    315       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      71     71       A -> S (in dbSNP:rs12233719).
FT                                /FTId=VAR_057327.
FT   VARIANT     268    268       H -> Y (in allele UGT2B7*2;
FT                                dbSNP:rs7439366).
FT                                {ECO:0000269|PubMed:11186130,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:15815621,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_012342.
FT   VARIANT     378    378       N -> S (in dbSNP:rs35590824).
FT                                /FTId=VAR_057328.
FT   MUTAGEN      15     15       S->A: Almost abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:17442341}.
FT   MUTAGEN      35     35       H->A: Almost abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:17442341}.
FT   MUTAGEN     151    151       D->A: Almost abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:17442341}.
FT   MUTAGEN     373    373       T->V: Almost abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:17442341}.
FT   MUTAGEN     374    374       H->A: Almost abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:17442341}.
FT   MUTAGEN     378    378       N->A: Strongly reduced enzyme activity.
FT                                {ECO:0000269|PubMed:17442341}.
FT   MUTAGEN     379    379       G->D: Almost abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:17442341}.
FT   MUTAGEN     398    398       D->A,N: Almost abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:17442341}.
FT   MUTAGEN     399    399       Q->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:17442341}.
FT   HELIX       290    297       {ECO:0000244|PDB:2O6L}.
FT   TURN        298    302       {ECO:0000244|PDB:2O6L}.
FT   STRAND      304    308       {ECO:0000244|PDB:2O6L}.
FT   HELIX       318    328       {ECO:0000244|PDB:2O6L}.
FT   STRAND      331    338       {ECO:0000244|PDB:2O6L}.
FT   STRAND      351    356       {ECO:0000244|PDB:2O6L}.
FT   HELIX       359    363       {ECO:0000244|PDB:2O6L}.
FT   STRAND      368    373       {ECO:0000244|PDB:2O6L}.
FT   HELIX       377    386       {ECO:0000244|PDB:2O6L}.
FT   STRAND      390    392       {ECO:0000244|PDB:2O6L}.
FT   HELIX       399    407       {ECO:0000244|PDB:2O6L}.
FT   TURN        408    410       {ECO:0000244|PDB:2O6L}.
FT   STRAND      411    414       {ECO:0000244|PDB:2O6L}.
FT   TURN        417    419       {ECO:0000244|PDB:2O6L}.
FT   HELIX       422    434       {ECO:0000244|PDB:2O6L}.
FT   HELIX       436    445       {ECO:0000244|PDB:2O6L}.
FT   TURN        448    450       {ECO:0000244|PDB:2O6L}.
SQ   SEQUENCE   529 AA;  60695 MW;  94B1CA6CE92F1446 CRC64;
     MSVKWTSVIL LIQLSFCFSS GNCGKVLVWA AEYSHWMNIK TILDELIQRG HEVTVLASSA
     SILFDPNNSS ALKIEIYPTS LTKTELENFI MQQIKRWSDL PKDTFWLYFS QVQEIMSIFG
     DITRKFCKDV VSNKKFMKKV QESRFDVIFA DAIFPCSELL AELFNIPFVY SLSFSPGYTF
     EKHSGGFIFP PSYVPVVMSE LTDQMTFMER VKNMIYVLYF DFWFEIFDMK KWDQFYSEVL
     GRPTTLSETM GKADVWLIRN SWNFQFPHPL LPNVDFVGGL HCKPAKPLPK EMEDFVQSSG
     ENGVVVFSLG SMVSNMTEER ANVIASALAQ IPQKVLWRFD GNKPDTLGLN TRLYKWIPQN
     DLLGHPKTRA FITHGGANGI YEAIYHGIPM VGIPLFADQP DNIAHMKARG AAVRVDFNTM
     SSTDLLNALK RVINDPSYKE NVMKLSRIQH DQPVKPLDRA VFWIEFVMRH KGAKHLRVAA
     HDLTWFQYHS LDVIGFLLVC VATVIFIVTK CCLFCFWKFA RKAKKGKND
//
